Nanovibronix, Inc. (NASDAQ:FEED) Sees Significant Decrease in Short Interest
by Renee Jackson · The Cerbat GemNanovibronix, Inc. (NASDAQ:FEED – Get Free Report) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 74,962 shares, a decline of 53.6% from the July 15th total of 161,665 shares. Based on an average daily trading volume, of 202,909 shares, the short-interest ratio is presently 0.4 days. Approximately 1.4% of the company’s stock are short sold.
Insider Activity
In other news, insider Christian Michael Glibert sold 210,000 shares of the company’s stock in a transaction dated Monday, June 22nd. The stock was sold at an average price of $0.69, for a total transaction of $144,900.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 12.20% of the company’s stock.
Nanovibronix Stock Performance
Shares of NASDAQ:FEED traded up $0.06 during midday trading on Friday, hitting $0.44. The company’s stock had a trading volume of 857,848 shares, compared to its average volume of 1,576,550. The stock has a market capitalization of $2.66 million, a price-to-earnings ratio of -0.05 and a beta of 1.38. The stock’s 50 day simple moving average is $0.52 and its 200 day simple moving average is $1.35. Nanovibronix has a fifty-two week low of $0.29 and a fifty-two week high of $17.40.
Nanovibronix (NASDAQ:FEED – Get Free Report) last posted its quarterly earnings data on Monday, May 18th. The company reported ($6.88) EPS for the quarter. Nanovibronix had a negative return on equity of 54.25% and a negative net margin of 923.20%.The business had revenue of $0.65 million during the quarter.
Wall Street Analyst Weigh In
FEED has been the subject of a number of recent analyst reports. Wall Street Zen raised Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Sunday, July 12th. Weiss Ratings restated a “sell (e+)” rating on shares of Nanovibronix in a research note on Tuesday, July 21st. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Nanovibronix has a consensus rating of “Sell”.
View Our Latest Research Report on FEED
About Nanovibronix
Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.
The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.